Massive things going forward for this company, most notably the seismic shift in how the FDA will approve AD drugs for use, and a BoD who understand the way to use this shift.
- Forums
- ASX - By Stock
- ACW
- Ann: Actinogen Ethics Committee approval for XanaMIA study
Ann: Actinogen Ethics Committee approval for XanaMIA study, page-42
Featured News
Add ACW (ASX) to my watchlist
|
|||||
Last
3.8¢ |
Change
-0.003(7.32%) |
Mkt cap ! $103.0M |
Open | High | Low | Value | Volume |
4.1¢ | 4.2¢ | 3.8¢ | $752.5K | 18.86M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 1802485 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 1393778 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 1782485 | 0.038 |
8 | 3024425 | 0.037 |
6 | 901554 | 0.036 |
4 | 3215000 | 0.035 |
1 | 250000 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 1393778 | 3 |
0.041 | 768915 | 4 |
0.042 | 447837 | 4 |
0.043 | 163174 | 2 |
0.044 | 387986 | 3 |
Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |